Plus Products: Top-Ranked Edibles in California


Tony Deyes

November 1st, 2018

Exclusive, News, Top News


Plus Products (CSE:PLUS) is one of the top five cannabis-infused edibles companies in the California market – the largest, most competitive in the United States and boasts two of the top ten selling edible products according to BDS Analytics . Plus Products recently went public on the Canadian Securities Exchange on October 30, 2018.

The company introduced its products in 2015, and has scaled its business and operations successfully  while maintaining its vision of making cannabis “safe and approachable”. Plus Products holds a temporary manufacturing license granted in California, and was one of the first to introduce fully compliant products under California’s regulated program that launched in January 2018.

The Plus development team includes chefs, chemists, engineers, food manufacturing experts, machinists, visionaries and creatives, who work collaboratively to pair high-quality extracts with carefully selected ingredients to create regulation-compliant, dosable and delicious products for adult consumers, medicinal and recreational alike. The result is consistent, low calorie but great tasting edibles. Its executive team has a proven record of savvy forward thinking and while there are plans for eventual expansion into additional markets, it remains laser focused on captivating the California market first.

Seizing on Market Shifts

Cannabis extract-based products are the fastest growing segment of the regulated cannabis industry, as customers (especially those new to cannabis) move away from smoking and explore new delivery options. Plus is well positioned to capitalize on this shift. Just like Colorado and Washington, the legalization of adult recreational use in California was accompanied by a sharp increase in the sale of cannabis-infused edibles, making up 18% of total marijuana-related sales in February alone.

California legalized adult recreational use on January 1, 2018 and by April, Plus had already realized $1.4 million in retail sales [in April alone] according to BDS Analytics. Later that same month, the company announced it had secured series B financing sufficient to allow it to expand its operations to meet the growing demand for its branded product. As a result of its fundraising (including its IPO, concluded in October 2018), Plus has the funding needed to build a full-scale, dedicated cannabis food manufacturing facility, enabling an estimated $150M in annual production, with the potential to expand to $450M.

The market is evolving rapidly, with massive growth in branded products, and Plus has proven itself a leader in the field. Its gummies are packaged in child-proof, resealable tins with distinctive labeling, in six current offerings, including two seasonal, limited edition flavours, each labelled Indica, Sativa, Hybrid, or CBD, and sold 20 pieces per tin.

Its Restore gummies are Indica, 9:1 THC to CBD, blackberry & lemon flavored, designed for customers who want to unwind. Its Uplift product is a sour watermelon-flavored Sativa gummy suited for daytime use. Create gummies are a sour blueberry Hybrid blend designed to boost mood and stimulate creativity. CBD Relief is pineapple & coconut flavored and designed to provide pain relief. Additionally, there are two seasonal offerings for 2018; Rainbow Sorbet sold during the summer – an anytime treat with a portion of the proceeds going to support a suicide prevention hotline for LGBT youth – and Rose & Vanilla, available throughout the winter and designed to put users in a loving mood.

Keeping Up With Growing Demand

Through its distribution partner, Plus Products currently sells to over 200 licensed dispensaries and delivery service customers, and an expanded product line is currently in the works. Recently-acquired candy manufacturing and packaging equipment will allow the company to boost its capacity from $7m to $50m annually, and an investment in testing equipment and key staff ensures consistency while bolstering research and development. The company believes its current manufacturing facilities are adequate in the short term but has been executing on its plan to expand as demand for its products grows.

For more information, please visit the company’s website: https://www.plusproducts.com/

Disclaimer

The above article is sponsored content. Emerging Growth LLC, which owns CannabisFN.com and CFN Media, has been hired to create awareness. Please follow the link below to view our full disclosure outlining our compensation: https://cannabisfn.com/legal-disclaimer/

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Tony Deyes



Network Partners

Follow Us on Social Media

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading